Concepedia

Daniel Woronow

DW

Statistics

Publications

4

Citations

98

H-Index

4

Active since

1984

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

Daniel Woronow is an author at United States Food and Drug Administration specializing in medicine, clinical pharmacology, and cardiology.

Publications per year

1984–2023

4

Publications

4

Acute Cholecystitis Associated With the Use of Glucagon-Like Peptide-1 Receptor Agonists Reported to the US Food and Drug Administration

Daniel Woronow, Christine Chamberlain, Ali Niak et al. · JAMA Internal Medicine · 2022 · 26 citations · Full text

Medicine, Endocrinology, Internal Medicine +11

Ibrutinib-associated ventricular arrhythmia in the FDA Adverse Event Reporting System

Connie Cheng, Daniel Woronow, Afrouz Nayernama et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2018 · 25 citations

Medicine, Cardiology, Pharmacology +16

Valsartan, Losartan and Irbesartan use in the USA, UK, Canada and Denmark after the nitrosamine recalls: a descriptive cohort study

Efe Eworuke, Mayura Shinde, Laura Hou et al. · BMJ Open · 2023 · 24 citations · Full text

Pharmacy, Cardiology, Pharmacology +17

Community‐acquired non‐A, non‐B hepatitis: Clinical characteristics and chronicity

Richard E. Sampliner, Daniel Woronow, Miriam J. Alter et al. · Journal of Medical Virology · 1984 · 23 citations

Medicine, Infectious Diseases, Internal Medicine +13

1–4 of 4